Formula & Concentration

Tetanus Immune Globulin (Human)

Manufacturer

Grifols

Indications

HyperTET S/D is indicated for prophylaxis against tetanus following injury in patients whose immunization is incomplete or uncertain (see below). It is also indicated, although evidence of effectiveness is limited, in the regimen of treatment of active cases of tetanus.7, 8, 15

A thorough attempt must be made to determine whether a patient has completed primary vaccination. Patients with unknown or uncertain previous vaccination histories should be considered to have had no previous tetanus toxoid doses. Persons who had military service since 1941 can be considered to have received at least one dose, and although most of them may have completed a primary series of tetanus toxoid, this cannot be assumed for each individual. Patients who have not completed a primary series may require tetanus toxoid and passive immunization at the time of wound cleaning and debridement.2

Product Options

Package Size

NDC #

Presentation

250 IU syringe

13533-0634-02

Syringe

Shelf Life and Storage

36 Months

Store at 2–8°C (36–46°F). Solution that has been frozen should not be used.